According to a financial filing, Vertex has decided to price Alyftrek at $370,269 per year, which is 7% higher than Trikafta's wholesale acquisition cost (WAC) of $346,048 per year. First ...

The final tournament kicks off on 2 July, with opening group games including Switzerland-Norway, Spain-Portugal, Denmark-Sweden and France-England.

Vertex Pharmaceuticals Presents “Unprecedented” Data for T1D Cell Therapy Zimislecel, Shows Durable Benefit. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks ...

Sales of the Trikafta/Kaftrio approached $1 billion in the third quarter, driving a 62% increase in revenues at the company even as even as Vertex' older therapies started to decline.

Vertex Pharmaceuticals Share Price Live Today:Get the Live stock price of VRTX Inc., and quote, performance, latest news to help you with stock trading and investing.Check out why Vertex ...

The NZZ offers fact-based analyses, in-depth investigations and top-notch reporting: a global view with a fresh perspective.

To learn more about security concerns and safety tips for Switzerland, check out the U.S. State Department's website. Explore More of . Geneva. Things To Do. Best Hotels. When To Visit.

Low commission rates start at $0 for U.S. listed stocks & ETFs*. Margin loan rates from 4.83% to 5.83%. Commission-free trading on stocks & ETFs. Earn $+0.06 per options contract and 5.1% APY on ...